What's new in Interventional Cardiology

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik

$Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial$

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Author

Yohei Ohno

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial

31 Mar 2025

Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.

Author

Jonathan Curio

Author

Raj Makkar

Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial

Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial

29 Mar 2025

Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.

Author

Aaysha Cader

Author

Ali Nazmi Calik

Routine cerebral embolic protection in TAVI: the British Heart Foundation (BHF) PROTECT-TAVI trial

The main results of the phase 3 Reverse-it trial

02 Apr 2025

Luis Ortega-Paz interviews Deepak L. Bhatt about the results of the Phase 3 Reverse-it trial which he presented during the ACC.25 in Chicago.

Author

Deepak L. Bhatt

Author

Luis Ortega-Paz

The main results of the phase 3 Reverse-it trial

Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI)

10 Apr 2025

Chiara De Biase interviews Sergio Raposeiras-Roubin about the results of the DapaTAVI trial which he presented during the ACC.25 in Chicago.

Author

Chiara De Biase

Author

Sergio Raposeiras-Roubin

Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI)

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)

31 Mar 2025

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Author

Nicola Ryan

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease

Best of science and education in cardiovascular interventional medicine in 2024

16 Dec 2024

Dear Colleagues, dear PCR Companions,

As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.

2024 was a record year...

PCRonline: Best of science & education in 2024

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2024

24 Nov 2024

View a snapshot of the results of these 3 trials presented in London: TRISCEND II, COMPARE-TAVI cohort B and the 30-day Outcomes of the TF J-VALVE for Chronic AR